International network of researchers aiming to accelerate vaccine development for TB, leishmaniasis, melioidosis &leprosy. Led by @UniofOxford - open to all

Oxford, England
Joined July 2017
Dr Hina Raxa, a pharmacist, vaccine researcher, and VALIDATE Associate from Pakistan, discusses the challenges of research in LMICs and how VALIDATE is helping her work and career. youtube.com/watch?v=5CT0KcfS…
67
At the VALIUDATE Annual Meeting 2026, Dr Chinedu Iwu from Ghana talked about how much he enjoyed the meeting and his excitement as a new member of our growing community youtu.be/Jps0z74vLxE?si=I7Zs…
2
79
🔬The VALIDATE Network is happy to have hosted a successful VALIDATE for Schools programme in collaboration with the Societal Impact Task Team at Stellenbosch University’s Biomedical Research Institute. A great deal was learned, and we had a lot of fun exploring science!
3
95
Dr Alison Kraigsley is joining #VALIDATE2026 to discuss @gatesfoundation funding opportunities and updates relevant to global health research.
1
2
107
Prof Marcela Henao-Tamayo is giving an investigator talk on mucosal priming and sex as determinants of tuberculosis vaccine efficacy. #VALIDATE2026
1
1
148
Prof Ivo Steinmetz, on behalf of Dr Gabriel Wagner-Lichtenegger, is taking delegates through the VALIDATE Pump-priming Project, Melio MuSe, using multiplex serology to advance multicomponent melioidosis vaccines. #VALIDATE2026
129
Dr Paula Niewold is presenting on behalf of Dr Anouk van Hooij’s VALIDATE Pump-priming Project, CCR4LEP, exploring CCR4 as an immune correlate of protection for leprosy. #VALIDATE2026
91
Assoc Prof Suraj Parihar is exploring the role of Sestrin 2 in tuberculosis disease in his investigator talk at #VALIDATE2026
83
Right now Dr Robert Krause, presenting his VALIDATE Fellowship research on a novel DNA-launched therapeutic for tuberculosis in murine and human models. #VALIDATE2026
1
4
100